Centene Corporation's stock surged over 13% following its robust Q1 2026 earnings report, revealing a revenue of $49.94 billion and adjusted earnings per share of $3.37, both exceeding analyst expectations. The positive momentum was further fueled by Bank of America's double upgrade, increasing Centene's price target to $60. Additionally, the firm improved its full-year revenue forecast to approximately $189.5 billion, reflecting strong performance in its Medicaid segment despite ongoing challenges in the marketplace.